The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • No Criteria Specification was provided in the publication event for the variant classifaction.
  • The Criteria Specification shown below is a best-estimate based on the VCEP, gene, disease, and publication date.

Variant: NM_001110792.2(MECP2):c.251C>T (p.Pro84Leu)

CA170269

143501 (ClinVar)

Gene: MECP2 (HGNC:4204)
Condition: Rett syndrome (MONDO:0010726)
Inheritance Mode: X-linked inheritance
UUID: 0867b6a6-269b-41ae-9f93-b57e0942ba44
Approved on: 2021-10-26
Published on: 2021-12-27

HGVS expressions

NM_001110792.2:c.251C>T
NM_001110792.2(MECP2):c.251C>T (p.Pro84Leu)
NC_000023.11:g.154032369G>A
CM000685.2:g.154032369G>A
NC_000023.10:g.153297820G>A
CM000685.1:g.153297820G>A
NC_000023.9:g.152951014G>A
NG_007107.2:g.109759C>T
NG_007107.3:g.109735C>T
ENST00000303391.11:c.215C>T
ENST00000453960.7:c.251C>T
ENST00000303391.10:c.215C>T
ENST00000369957.5:c.*269C>T
ENST00000407218.5:c.251C>T
ENST00000453960.6:c.251C>T
ENST00000486506.5:n.2563C>T
ENST00000611468.1:c.203C>T
ENST00000619732.4:c.215C>T
ENST00000622433.4:c.203C>T
ENST00000628176.2:c.215C>T
NM_001110792.1:c.251C>T
NM_001316337.1:c.-65C>T
NM_004992.3:c.215C>T
NM_001316337.2:c.-65C>T
NM_001369391.2:c.-65C>T
NM_001369392.2:c.-65C>T
NM_001369393.2:c.-65C>T
NM_001369394.1:c.-65C>T
NM_001369394.2:c.-65C>T
NM_001386137.1:c.-346C>T
NM_001386138.1:c.-346C>T
NM_001386139.1:c.-346C>T
NM_004992.4:c.215C>T
More

Likely Benign

Met criteria codes 2
BS2_Supporting BS1
Not Met criteria codes 1
BP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The allele frequency of the p.Pro72Leu variant in MECP2 (NM_004992.3) is 0.01338% in the Ashkenazi Jewish sub population in gnomAD, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). The p.Pro72Leu variant is observed in at least 1 unaffected individual (internal database - Invitae) (BS2_supporting). In summary, the p.Pro72Leu variant in MECP2 is classified as Likely Benign based on the ACMG/AMP criteria (BS1, BS2_supporting).
Met criteria codes
BS2_Supporting
The p.Pro72Leu variant is observed in at least 1 unaffected individual (internal database - Invitae).
BS1
The allele frequency of the p.Pro72Leu variant in MECP2 is 0.01338% in the Ashkenazi Jewish sub population in gnomAD, which is high enough to be classified as likely benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions.
Not Met criteria codes
BP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.